Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Incyte Corp (INCY)
NASDAQ:INCY
Incyte (INCY) Stock Price & Analysis
1,386 Followers
INCY Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$65.07 - $86.29
Previous Close$84.36
Volume4.17M
Average Volume (3M)1.46M
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)$2.98B
Total Debt (Recent Filing)$42.08M
Price to Earnings (P/E)21.4
Beta0.59
Next EarningsMay 02, 2023
EPS Estimate$0.5
Next Dividend Ex-DateN/A
Dividend YieldN/A
1Y Price Target$91.25
EPS (TTM)3.94
Shares Outstanding222,475,468
R-Squared0.18
Standard Deviation0.09
10 Day Avg. Volume1,433,795
30 Day Avg. Volume1,462,083
Price to Book (P/B)4.81
Price to Sales (P/S)7.72
Price to Cash Flow (P/CF)23.70
P/FCF Ratio30.10
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside12.71% Upside
Rating ConsensusModerate Buy
Alpha-0.00238
Number of Analyst Covering9
Incyte News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
INCY FAQ
What was Incyte’s price range in the past 12 months?
Incyte lowest stock price was $65.07 and its highest was $86.29 in the past 12 months.
What is Incyte’s market cap?
Currently, no data Available
When is Incyte’s upcoming earnings report date?
Incyte’s upcoming earnings report date is May 02, 2023 which is in 83 days.
How were Incyte’s earnings last quarter?
Incyte released its earnings results on Feb 07, 2023. The company reported $0.13 earnings per share for the quarter, missing the consensus estimate of $0.3 by -$0.17.
Is Incyte overvalued?
According to Wall Street analysts Incyte’s price is currently Undervalued.
Does Incyte pay dividends?
Incyte does not currently pay dividends.
What is Incyte’s EPS estimate?
Incyte’s EPS estimate is $0.5.
How many shares outstanding does Incyte have?
Incyte has 222,475,460 shares outstanding.
What happened to Incyte’s price movement after its last earnings report?
Incyte reported an EPS of $0.13 in its last earnings report, missing expectations of $0.3. Following the earnings report the stock price went up 3.511%.
Which hedge fund is a major shareholder of Incyte?
Among the largest hedge funds holding Incyte’s share is Dodge & Cox. It holds Incyte’s shares valued at 1B.
---
Incyte Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$91.25
$91.25
Blogger Sentiment
Bullish
INCY Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 451.8K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Neutral
Last 7 Days ▲ 0.2%
Last 30 Days ▲ 0.7%
Last 30 Days ▲ 0.7%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
16.05%
12-Months-Change
Fundamentals
Return on Equity
23.76%
Trailing 12-Months
Asset Growth
31.23%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Incyte Corp
Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development and commercialization of proprietary therapeutics. Its portfolio includes compounds in various stages, ranging from preclinical to late stage development, and commercialized products such as JAKAFI (ruxolitinib), and ICLUSIG (ponatinib). The company was founded by Roy A. Whitfield in April 1991 and is headquartered in Wilmington, DE.
---
---